Lv1
50 积分 2025-06-28 加入
Guselkumab in East Asians With Moderate‐to‐Severe Ulcerative Colitis: Subgroup Analysis of the QUASAR Induction and Maintenance Studies
4个月前
已完结
Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis: QUASAR Phase 2b Induction Study
4个月前
已完结
Guselkumab plus golimumab combination therapy versus guselkumab or golimumab monotherapy in patients with ulcerative colitis (VEGA): a randomised, double-blind, controlled, phase 2, proof-of-concept trial
4个月前
已完结
Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis: QUASAR Phase 2b Induction Study
5个月前
已完结
Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studies
5个月前
已完结
Ulcerative Colitis in Adults
5个月前
已完结
Ulcerative Colitis in Adults
5个月前
已完结
Ulcerative colitis: clinical biomarkers, therapeutic targets, and emerging treatments
5个月前
已完结
Ulcerative colitis
5个月前
已完结
Protective function of sclerosing cholangitis on IBD
7个月前
已完结
皖公网安备34019202002308
